Are you Dr. Kaye?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 29 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
500 Kendall St
Cambridge, MA 02142Phone+1 617-768-6129- Is this information wrong?
Summary
- Dr. Edward Kaye, MD is a Child Neurologist in Cambridge, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Pennsylvania, and Texas. He is a Lecturer on Neurology at Boston Children's Hospital.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 2015 - 2018
Boston University Medical CenterResidency, Neurology, 1978 - 1981
Loyola University Medical CenterResidency, Pediatrics, 1975 - 1978
Loyola University Chicago Stritch School of MedicineClass of 1975
Certifications & Licensure
MA State Medical License 1986 - 2026
PA State Medical License 1996 - 2018
TX State Medical License 1983 - 1987
IL State Medical License 1977 - 1984- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Study of Eteplirsen in DMD Patients Start of enrollment: 2014 Nov 17
Publications & Presentations
PubMed
- 231 citationsNatural history of infantile-onset spinal muscular atrophy.Stephen J. Kolb, Christopher S. Coffey, Jon W. Yankey, Kristin J. Krosschell, W. David Arnold, Seward B. Rutkove, Kathryn J. Swoboda, Sandra P. Reyna, Ai Sakonju, Basi...> ;Annals of Neurology. 2017 Dec 1
- 51 citationsCategorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophyEugenio Mercuri, James Signorovitch, Elyse Swallow, Jinlin Song, S. Ward, Marika Pane, Elena S. Mazzone, Sonia Messina, Gianluca Vita, M. P. Sormani, Adele D'Amico, An...> ;Neuromuscular Disorders. 2016 Sep 1
- 67 citationsStakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophyVolker Straub, Pavel Balabanov, Kate Bushby, Monica Ensini, Nathalie Goemans, Annamaria De Luca, Alejandra Pereda, Robert Hemmings, G. Campion, Edward M. Kaye, Virgini...> ;The Lancet. Neurology. 2016 Jul 1
- Join now to see all
Press Mentions
- Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business UpdatesAugust 10th, 2021
- Stoke Therapeutics to Present at Upcoming Investor Conferences in AugustAugust 3rd, 2021
Stoke Therapeutics to Present at Canaccord Genuity 39th Annual Growth ConferenceFebruary 24th, 2020- Join now to see all
Grant Support
- Molecular Genetic Studies Of GM1 GanglionNational Institute Of Neurological Disorders And Stroke1994
- Molecular Genetic Studies Of Human GM1 GanglionNational Institute Of Neurological Disorders And Stroke1990–1993
